click below
click below
Normal Size Small Size show me how
Tox Vocab 2
| Question | Answer |
|---|---|
| Cumulative exposure | This is a summation of all the exposures that have been undergone by an organism during a specified period of time. |
| Cytotoxic | These are agents which are toxic to cells. |
| Dermatitis | This is an inflammatory response of the skin and is characterised by symptoms which include redness, pain and itchiness. |
| Developmental toxicology | This studies the effects on the normal developmental process of the offspring from the time it is in the mother’s womb until postnatal development. |
| DNEL (Derived No Effect Level) | This is the level of exposure (measured as a dose) above which humans should not be exposed. It is derived by the evaluation of all available hazard data for the substance in question and the relevant Noaels or Loaels. |
| Dominant lethal assay | This provides an indication of chemicals which can cause embryonic or foetal death; mainly as a result of causing structural/numerical chromosomal abnormalities in the germ cells. |
| Dose | This is defined as the amount of substance (that comes in contact with the organism) per unit weight of organism. It is a measure of exposure. |
| Dose-response curves | graphical representations of the relationship between the response (expressed as severity of measured response or proportion of the test population responding) being measured & administered dose in toxicological studies such as repeated dose tox studies |
| Elimination/excretion | The removal of a chemical from the body. This occurs mostly via exhalation of air, or in the urine or faeces. |
| Endocrine active substances | These are any chemicals which can interact directly or indirectly with the endocrine system, and subsequently result in an effect on the endocrine system, target organs and tissues. |
| Endocrine disruptor | An endocrine disruptor is an exogenous substance or mixture that alters functions of the endocrine system and consequently can cause adverse health effects in an intact organism or its progeny or (sub)populations |
| End point | This is a measurable/observable intrinsic toxicological effect related to the chemical in question. For example carcinogenicity, irritation potential, sensitising effects are all examples of toxicological endpoints. |
| Epidemiology | This is the study of the incidence and distribution of disease in populations. |
| Exposure | This is essentially “contact” with a chemical and the most common routes are inhalation, skin contact and also by oral ingestion. |
| Exposure scenarios | These detail the conditions under which a chemical may be safely used for an identified activity. They provide information on properties, operational conditions of use and appropriate risk management measures. |
| Ex vivo | This is Latin for “Out of the living.” That is, studies where living cells/tissues or even organs, etc. are removed from a living organism and then used in a toxicity study to determine the effects of chemical exposure. |
| Eye irritant | This is a chemical which gives rise to “The production of changes in the eye after test to surface of the eye, which are gone 21 days.” An eye corrosive as “the production of tissue damage in the eye, or serious physical decay of vision, no gone 21 days |
| Fertility | This is the ability to successfully conceive and produce offspring. |
| First pass metabolism (effect) | This is where the concentration of the absorbed chemical is greatly reduced (as a result of metabolism), prior to entering the general circulation. It is effectively a form of elimination. |
| Gavage | This is a form of oral dosing where the chemical substance is introduced into the stomach by means of a tube. |
| Genotoxic | This relates to chemicals that cause hereditary mutations as a result of directly interacting with the DNA. |
| Genotoxic carcinogens | These are chemicals which are able to cause cancer as a result of directly interacting with DNA. |
| Hapten | This is a small chemical molecule which can only cause an immune response when attached to a carrier protein in the body. |